Benitec Biopharma (NASDAQ:BNTC) Receives “Buy” Rating from HC Wainwright
HC Wainwright reiterated their buy rating on shares of Benitec Biopharma (NASDAQ:BNTC – Free Report) in a report published on Monday morning,Benzinga reports. They currently have a $28.00 target price on the biotechnology company’s stock. Separately, JMP Securities restated a “market outperform” rating and set a $20.00 price objective on shares of Benitec Biopharma in […]
HC Wainwright reiterated their buy rating on shares of Benitec Biopharma (NASDAQ:BNTC – Free Report) in a report published on Monday morning,Benzinga reports. They currently have a $28.00 target price on the biotechnology company’s stock. Separately, JMP Securities restated a “market outperform” rating and set a $20.00 price objective on shares of Benitec Biopharma in […]
